Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1995-04-04
1999-12-07
Jones, W. Gary
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 231, 536 243, 935 76, 935 77, 935 78, C07H 1900, C07H 2102, C07H 2104, C12N 1500
Patent
active
059985968
ABSTRACT:
The present invention are oligonucleotides that specifically bind to and directly inhibit the biological function of target molecules such as proteins, peptides or derivatives. The direct or aptameric interaction of oligonucleotides of the present invention with proteins, peptides and derivatives represents a non-antisense mediated effect. The oligonucleotides have been shown to bind to isolated target molecules and to inhibit biological function of the target molecule within cells. In particular, the oligonucleotides have been shown to directly inhibit the kinase activity of protein-tyrosine kinase. The oligonucleotides of the present invention have significant beneficial effects against a chronic myelogenous leukemia derived cell line as demonstrated using cellular phosphotyrosine content as well as cellular growth in soft agar.
REFERENCES:
patent: 5194599 (1993-03-01), Froehler et al.
patent: 5256775 (1993-10-01), Froehler et al.
patent: 5264562 (1993-11-01), Matteucci
patent: 5582981 (1996-12-01), Toole et al.
patent: 5629147 (1997-05-01), Asgari et al.
Shah et al., Molecular and Cellular Biology 11(4): 1854-1860 (1991).
Shtivelman et al., Cell 47(2): 277-284 (1986).
Shtivelman et al., Nature 315 :550-554 (1985).
The Boehringer Mannheim Biochemicals Catalog, 1990-91 Edition, pp. 139-140 and 226-227.
Gerkin et al. Genbank Accession No.: L18690 submitted to Genbank on May 27, 1993.
Peles et al., EMBO 10 (8): 2077-2086 (1991).
The Boehringer Mannheim Biochemicals Catalog, 1990-91 Edition, pp. 226-227.
Shtivelman et al. Cell 47: 277-284 (1986).
Bergan et al. Nucleic Acids Research 22(11): 2150-2154 (1994).
Wang et al. Biochemistry 32: 1899-1904 (1993).
Paborsky et al. The Journal of Biological Chemistry 268 (28): 20,808-20,811 (1993).
Conrad et al. The Journal of Biological Chemistry 269(51):32,051-32,054 (Dec. 1994).
Darnell et al. "Molecular Cell Biology", pp. 110-114 Scientific American Books New York, NY (1986).
Bergan et al, Aptameric Inhibition of p210.sup.bcr-abl Tyrosine Kinase Autophosphorylation by Oligodeoxynucleotides of Defined Sequence and Backbone Structure, Nucleic Acids Research, 1994, vol. 22, No. 11, pp. 2150-2154.
Bergan et al, Synthetic Oligonucleotides: Potent Aptameric Inhibitors of Protein Tyrosine Kinases, J. of Biochemistry, Mar. 29, 1993, Keystone Symposium, Abstract S400, p. 210.
Gao et al, Inhibition of Herpes Simplex Virus Type 2 Growth by Phosphorothioate Oligodeoxynucleotides, Antimicrobial Agents and Chemotherapy, May 1990, vol. 34, No. 5, pp. 808-812.
Marshall et al, Phosphorodithioate DNA as a Potential Therapeutic Drug, Science, vol. 259, Mar. 12, 1993, pp. 1564-1570.
Tuerk et al, RNA Pseudoknots That Inhibit Human Immunodeficiency Virus Type 1 Reverse Transcriptase, Proc. Natl. Acad. Sci. USA, vol. 89, Aug. 1992, pp. 6988-6992.
Wang et al, The Tertiary Structure of a DNA Aptamer Which Binds to and Inhibits Thrombin Determines Activity, Biochemistry, 1993, 32, pp. 11285-11292.
Padmanabhan et al, The Structure of .alpha.-Thrombin Inhibited by a 15-mer Single-Stranded DNA Aptamer, The Journal of Biological Chemistry, vol. 268, No. 24, Aug. 25, 1993, pp. 17651-17654.
Latham et al, The Application of a Modified Nucleotide in Aptamer Selection: Novel Thrombin Aptamers Containing 5-(1-Pentynyl)-2'-Deoxyuridine, Nucleic Acids Research, vol. 22, No. 14, 1994, pp. 2817-2822.
Griffin et al, The Discovery and Charcterization of a Novel Nucleotide-Based Thrombin Inhibitor, Gene, vol. 137, No. 1, 1993, pp. 25-31.
Bock et al, Selection of Single-Stranded DNA Molecules That Bind and Inhibit Human Thrombin, Nature, vol. 355, Feb. 6, 1992, pp. 564-566.
Bergan Raymond
Neckers Len
Jones W. Gary
The United States of America as represented by the Department of
Whisenant Ethan
LandOfFree
Inhibition of protein kinase activity by aptameric action of oli does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of protein kinase activity by aptameric action of oli, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of protein kinase activity by aptameric action of oli will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-825343